Clinical Trial Update: A Study To Test An Anti-Rejection Therapy After Kidney Transplantation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating an anti-rejection therapy after kidney transplantation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Kidney Transplantation | Phase 3 | Status: TERMINATED